imatinib mesylate has been researched along with Nerve Degeneration in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Anonetapipat, JW; Gozal, D; Gozal, E; Simakajornboon, N; Szerlip, NJ | 1 |
1 other study(ies) available for imatinib mesylate and Nerve Degeneration
Article | Year |
---|---|
In vivo PDGF beta receptor activation in the dorsocaudal brainstem of the rat prevents hypoxia-induced apoptosis via activation of Akt and BAD.
Topics: Animals; Apoptosis; bcl-Associated Death Protein; Benzamides; Carrier Proteins; Caspases; Cell Survival; DNA, Single-Stranded; Enzyme Inhibitors; Hypoxia, Brain; Imatinib Mesylate; Immunohistochemistry; Male; Nerve Degeneration; Neurons; Neuroprotective Agents; Phosphorylation; Piperazines; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Pyrimidines; Rats; Rats, Sprague-Dawley; Receptor, Platelet-Derived Growth Factor beta; Respiratory Physiological Phenomena; Signal Transduction; Solitary Nucleus | 2001 |